MEDOF (Medios AG) Short Ratio


MEDOF Medios AG MEDOF
88 GF Score
Price $50.00
GF Value $71.50
! 2 Warning Signs
View Full Analysis

What is Medios AG Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEDOF
88GF Score
Medios AG MEDOF
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medios AG (MEDOF) Overvalued in 2026?

Based on GuruFocus' analysis, Medios AG stock appears to be undervalued. The current stock price of $50.00 is trading 30.1% below its estimated GF Value™ of $71.50.

Key valuation signals for MEDOF:

  • Short Ratio:
  • GF Value™: $71.50 vs. price of $50.00 (30.1% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medios AG Business Description

Address Heidestrasse 9, Berlin, DEU, 10557
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score

Get the complete analysis for MEDOF

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$50.00
Price
$71.50
GF Value